Literature DB >> 8581067

NFI/X proteins: a class of NFI family of transcription factors with positive and negative regulatory domains.

G Nebl1, A C Cato.   

Abstract

NFI is a family of transcription factors that binds discrete nucleotide sequence and regulates transcriptional activity of genes. Transactivation occurs through proline-rich sequences. Among the genes whose transcriptional activity is regulated are those expressed in a cell-type specific manner. This suggests the possible existence of NFI proteins with distinct properties. With the use of the polymerase chain reaction technique, we have cloned and analyzed the activity of three spliced variants of NFI (class X) genes in murine cells. Expression vectors containing the regulatory regions of these proteins fused to the DNA binding domain of the yeast transcription factor GAL4 helped identify both negative and positive regulatory domains. In the context of the whole NFI/X proteins, spliced variants lacking the positive regulatory sequences functioned as repressors, whereas those containing both regulatory domains functioned as weak activators. With the identification of the negative domain in the NFI/X proteins, we demonstrate here a novel regulatory feature of these proteins in positive and negative modulation of gene expression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8581067

Source DB:  PubMed          Journal:  Cell Mol Biol Res        ISSN: 0968-8773


  10 in total

Review 1.  The Nuclear Factor I (NFI) gene family in mammary gland development and function.

Authors:  Janice Murtagh; Finian Martin; Richard M Gronostajski
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

2.  Increased induction of osteopetrosis, but unaltered lymphomagenicity, by murine leukemia virus SL3-3 after mutation of a nuclear factor 1 site in the enhancer.

Authors:  S Ethelberg; B D Tzschaschel; A Luz; S J Diaz-Cano; F S Pedersen; J Schmidt
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

3.  The unique transcriptional activation domain of nuclear factor-I-X3 is critical to specifically induce marker gene expression in astrocytes.

Authors:  Sandeep K Singh; Katarzyna M Wilczynska; Adrian Grzybowski; Jessie Yester; Bahiya Osrah; Lauren Bryan; Sarah Wright; Irene Griswold-Prenner; Tomasz Kordula
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

4.  CTF5--a new transcriptional activator of the NFI/CTF family.

Authors:  S Wenzelides; H Altmann; W Wendler; E L Winnacker
Journal:  Nucleic Acids Res       Date:  1996-06-15       Impact factor: 16.971

5.  A combination of MEF3 and NFI proteins activates transcription in a subset of fast-twitch muscles.

Authors:  F Spitz; M Salminen; J Demignon; A Kahn; D Daegelen; P Maire
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

6.  Nuclear factor 1 (NF1) affects accurate termination and multiple-round transcription by human RNA polymerase III.

Authors:  Z Wang; L Bai; Y J Hsieh; R G Roeder
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

7.  A member of the nuclear factor-1 family is involved in the pituitary repression of the human placental growth hormone genes.

Authors:  L D Norquay; Y Jin; R M Surabhi; R D Gietz; N Tanese; P A Cattini
Journal:  Biochem J       Date:  2001-03-01       Impact factor: 3.857

8.  The C-terminal domain of the nuclear factor I-B2 isoform is glycosylated and transactivates the WAP gene in the JEG-3 cells.

Authors:  Sudit S Mukhopadhyay; Jeffrey M Rosen
Journal:  Biochem Biophys Res Commun       Date:  2007-05-07       Impact factor: 3.575

9.  New insights into FoxE1 functions: identification of direct FoxE1 targets in thyroid cells.

Authors:  Lara P Fernández; Arístides López-Márquez; Angel M Martínez; Gonzalo Gómez-López; Pilar Santisteban
Journal:  PLoS One       Date:  2013-05-13       Impact factor: 3.240

10.  Epigenome-wide association study of smoking and DNA methylation in non-small cell lung neoplasms.

Authors:  Joshua R Freeman; Su Chu; Thomas Hsu; Yen-Tsung Huang
Journal:  Oncotarget       Date:  2016-10-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.